Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Improving diabetes care for Latinos using e-health tools

Official title: Latinos Understanding the Need for Adherence in Diabetes Using Care Coordination, Integrated Medical and Behavioral Care and E-Health

Run by San Diego State University · NCT05570734 · Data updated 2026-11-12

This study is testing whether using online tools and support can help Latino patients with type 2 diabetes manage their condition better and feel less stressed.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment400 (estimated)
SponsorSan Diego State University
Academic / other
Locations1 site (Chula Vista, California)
StatusRecruiting
StartedFebruary 27, 2023
Main results expectedAugust 2025
Study endsFebruary 2026
Registry record updatedJanuary 17, 2025
Trial IDNCT05570734 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Latino adults aged 18 and older with type 2 diabetes and a hemoglobin A1C level greater than 7.5%.

Probably not a fit

Patients with severe diabetes complications or those actively treated for other serious health conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The LUNA-E project is a randomized controlled trial aimed at enhancing diabetes management among Latino patients through a patient-centered, team-based approach that incorporates e-health technologies. The study will enroll 400 participants with type 2 diabetes from a federally qualified health center, focusing on improving glycemic control and reducing psychological distress. Participants will receive care coordination, behavioral health support, and health education via virtual visits and videos. Biological and psychosocial measures will be collected at multiple time points to assess the intervention's effectiveness.

Why it matters

Potential benefit: If successful, this intervention could significantly improve diabetes management and mental health outcomes for Latino patients.

How similar studies have gone: Other studies have shown promise in using technology and community-based approaches for diabetes management, suggesting potential success for this intervention.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Self identify as Hispanic/Latino ethnicity of any race
2. Registered patient of federally qualified health center
3. 18 years of age or older
4. Type 2 diabetes with hemoglobin A1C (HbA1c) \>7.5% in past 90 days
5. Approval from primary care provider
6. Not currently enrolled/participating in any other diabetes intervention program(s)

Exclusion Criteria:

1. Actively being treated for cancer or Parkinson's Disease
2. Pregnant or nursing (temporary exclusion, may qualify 6-months postpartum)
3. Have plans to move out of the area in the next 12 months
4. Have other existing mental or physical health problems so severe as to prohibit informed consent and participation
5. Have severe diabetes complications (e.g., renal disease, or on dialysis)

Where it's running

  • South Bay Latino Research Center
    Chula Vista, California, United States
    Recruiting

Study contacts

  • Principal investigator: Gregory A Talavera, MD/MPH — San Diego State University
  • Study coordinator: Program Manager
  • Email: pmendoza@sdsu.edu
  • Phone: 619-594-8060

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.